Compound E, chemically designated as 209986-17-4 (CAS), represents a significant investigation within the field of Alzheimer's disease research. This γ-secretase blocking agent was initially developed as a potential https://laytnujbe353737.activoblog.com/51187788/γ-secretase-blocker-compound-e-209986-17-4